Skip to main content

Silverback Therapeutics, Inc. (NASDAQ: SBTX) Investor Securities Class Action Lawsuit 11/05/2021

  • If you purchased shares of Silverback Therapeutics, Inc. (NASDAQ: SBTX), you have certain options and for certain investors are short and strict deadlines running. Deadline: January 4, 2022. NASDAQ: SBTX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

  April 12, 2023 - The court issued an order granting motion to dismiss, the case was dismissed with prejudice. January 2, 2023 - A motion was filed to dismiss the amended complaint. December 5, 2022 - A second amended complaint was filed. November 4, 2022 - The court issued an order granting motion to dismiss. May 26, 2022 - A motion to dismiss the amended complaint was filed. April ...

You must register (for free) or login to view the entire case.